The prevention or treatment of breast cancer could be associated with inhibition of the mechanisms that govern the estrogen activity, such as the antagonism of the estrogen receptor or the inhibition of estrogen synthesis (58). The gene discussed is ESR1; the disease is breast carcinoma.